Senator slams GlaxoSmithKline over cost of asthma inhalers
Washington Post
Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow.
https://www.washingtonpost.com/business/2024/05/01/glaxosmithkline-inhaler-prices/